Novan to Present at the Cantor Fitzgerald Virtual Global Healthcare Conference

Rhea-AI Summary

Novan, Inc. (Nasdaq: NOVN) announced that Paula Brown Stafford, President and CEO, will participate in a fireside chat at the Cantor Fitzgerald Virtual Global Healthcare Conference on September 28, 2021, at 8:00 AM ET. The event is hosted by Jennifer Kim, VP of Equity Research.

The company’s management will also engage in virtual one-on-one meetings with qualified investors. A webcast of the chat will be available on Novan's website for 90 days post-event. Novan is focused on developing nitric oxide-based therapies for dermatology and anti-infective treatments using its proprietary platform, NITRICIL™.

– Live fireside chat with Paula Brown Stafford, President and Chief Executive Officer of Novan on Tuesday, September 28 at 8:00 AM ET –

DURHAM, N.C., Sept. 20, 2021 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (Nasdaq: NOVN), today announced that Paula Brown Stafford, President and Chief Executive Officer of Novan, will participate in a fireside chat hosted by Jennifer Kim, Vice President, Equity Research, at the Cantor Fitzgerald Virtual Global Healthcare Conference on Tuesday, September 28, 2021 at 8:00 AM ET.

In addition to the fireside chat, management will be available to participate in virtual one-on-one meetings with qualified members of the investor community who are registered to attend the conference.

A webcast of the live fireside chat will be accessible on the Events page in the Investors section of the Company’s website (novan.com) and available for 90 days following the event.

About Novan

Novan, Inc. is a pre-commercial nitric oxide-based pharmaceutical company focused on dermatology and anti-infective therapies. We leverage our core synergies of science, capital, resources and patient needs to create value by bringing new nitric oxide-based medicines to market. Our goal is to create the world’s leader in nitric oxide-based science, technology, and clinical translation in support of delivering safe and efficacious therapies using our proprietary nitric oxide-based technology platform, NITRICIL™ to generate macromolecular New Chemical Entities (NCEs) to treat multiple indications.

INVESTOR AND MEDIA CONTACT:
Jenene Thomas
JTC Team, LLC
833-475-8247
NOVN@jtcir.com

FAQ

When is Novan's fireside chat with Paula Brown Stafford scheduled?

The fireside chat with Paula Brown Stafford is scheduled for September 28, 2021, at 8:00 AM ET.

Where can I watch the Novan fireside chat?

The Novan fireside chat will be accessible on the company's website under the Events section and available for 90 days after the event.

Who is hosting the fireside chat for Novan?

The fireside chat for Novan will be hosted by Jennifer Kim, Vice President of Equity Research.

What is the focus of Novan, Inc. as a company?

Novan, Inc. focuses on developing nitric oxide-based pharmaceutical therapies, particularly in dermatology and anti-infective treatments.

What technology platform does Novan use for its drug development?

Novan uses its proprietary technology platform called NITRICIL™ for developing new nitric oxide-based medicines.